Pancreatic Cancer Research

ResearcherUniversity of North Carolina at Chapel HillActive in the last 2 years

Lei Miao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0004-1647-1445; OpenAlex author ID A5100697160. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Engineered exosome-lymphotropic mRNA vaccine encoding series-connected antigens elicits potent antitumor immunity in pancreatic cancer. Co-author DOI 10.1016/j.ijpharm.2026.127327↗
  2. Transient and Local Expression of Chemokine and Immune Checkpoint Traps To Treat Pancreatic Cancer. Co-author DOI 10.1021/acsnano.7b01786↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yijia Li · 1 shared paper, 2026 · strength 0.27
  2. Xueqing Wang · 1 shared paper, 2026 · strength 0.27
  3. Rihe Liu · 1 shared paper, 2017 · strength 0.07
  4. Manisit Das · 1 shared paper, 2017 · strength 0.07
  5. Jingjing Li · 1 shared paper, 2017 · strength 0.07
  6. Leaf Huang · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.